Newly detected diabetes during the COVID-19 pandemic: What have we learnt?

IF 6.1 1区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Dhruti Hirani (Internal Medicine Trainee) , Victoria Salem (Diabetologist & Diabetes UK Grand Challenge Senior Fellow) , Kamlesh Khunti (Professor of Primary Care Diabetes & Vascular Medicine) , Shivani Misra (Senior Clinical Lecturer & Wellcome Trust Career Development Fellow)
{"title":"Newly detected diabetes during the COVID-19 pandemic: What have we learnt?","authors":"Dhruti Hirani (Internal Medicine Trainee) ,&nbsp;Victoria Salem (Diabetologist & Diabetes UK Grand Challenge Senior Fellow) ,&nbsp;Kamlesh Khunti (Professor of Primary Care Diabetes & Vascular Medicine) ,&nbsp;Shivani Misra (Senior Clinical Lecturer & Wellcome Trust Career Development Fellow)","doi":"10.1016/j.beem.2023.101793","DOIUrl":null,"url":null,"abstract":"<div><p>The SARS-CoV-2 pandemic has had an unprecedented effect on global health, mortality and healthcare provision. Diabetes has emerged as a key disease entity over the pandemic period, influencing outcomes from COVID-19 but also a tantalising hypothesis that the virus itself may be inducing diabetes. An uptick in diabetes cases over the pandemic has been noted for both type 1 diabetes (in children) and type 2 diabetes but understanding how this increase in incidence relates to the pandemic is challenging. It remains unclear whether indirect effects of the pandemic on behaviour, lifestyle and health have contributed to the increase; whether the virus itself has somehow mediated new-onset diabetes or whether other factors such as stress hyperglycaemic of steroid treatment during COVID-19 infection have played a roll. Within the myriad possibilities are some real challenges in interpreting epidemiological data, assigning diabetes type and understanding what in vitro data are telling us. In this review article we address the issue of newly-diagnosed diabetes during the pandemic, reviewing both epidemiological and basic science data and bringing together both strands of this emerging story.</p></div>","PeriodicalId":8810,"journal":{"name":"Best practice & research. Clinical endocrinology & metabolism","volume":"37 4","pages":"Article 101793"},"PeriodicalIF":6.1000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303323/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Best practice & research. Clinical endocrinology & metabolism","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1521690X23000672","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 1

Abstract

The SARS-CoV-2 pandemic has had an unprecedented effect on global health, mortality and healthcare provision. Diabetes has emerged as a key disease entity over the pandemic period, influencing outcomes from COVID-19 but also a tantalising hypothesis that the virus itself may be inducing diabetes. An uptick in diabetes cases over the pandemic has been noted for both type 1 diabetes (in children) and type 2 diabetes but understanding how this increase in incidence relates to the pandemic is challenging. It remains unclear whether indirect effects of the pandemic on behaviour, lifestyle and health have contributed to the increase; whether the virus itself has somehow mediated new-onset diabetes or whether other factors such as stress hyperglycaemic of steroid treatment during COVID-19 infection have played a roll. Within the myriad possibilities are some real challenges in interpreting epidemiological data, assigning diabetes type and understanding what in vitro data are telling us. In this review article we address the issue of newly-diagnosed diabetes during the pandemic, reviewing both epidemiological and basic science data and bringing together both strands of this emerging story.

Abstract Image

Abstract Image

新冠肺炎大流行期间新发现的糖尿病:我们学到了什么?
严重急性呼吸系统综合征冠状病毒2型疫情对全球健康、死亡率和医疗保健产生了前所未有的影响。在大流行期间,糖尿病已成为一个关键的疾病实体,影响着新冠肺炎的结果,但也有一个诱人的假设,即病毒本身可能会诱导糖尿病。1型糖尿病(儿童)和2型糖尿病的糖尿病病例在疫情期间都有所增加,但了解发病率的增加与疫情的关系是一项挑战。目前尚不清楚疫情对行为、生活方式和健康的间接影响是否导致了这一增长;病毒本身是否以某种方式介导了新发糖尿病,或者新冠肺炎感染期间类固醇治疗的应激性高血糖等其他因素是否起了作用。在无数的可能性中,在解释流行病学数据、确定糖尿病类型和理解体外数据告诉我们的信息方面存在一些真正的挑战。在这篇综述文章中,我们讨论了疫情期间新诊断的糖尿病问题,回顾了流行病学和基础科学数据,并将这一新兴故事的两个方面结合起来。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
11.90
自引率
0.00%
发文量
77
审稿时长
6-12 weeks
期刊介绍: Best Practice & Research Clinical Endocrinology & Metabolism is a serial publication that integrates the latest original research findings into evidence-based review articles. These articles aim to address key clinical issues related to diagnosis, treatment, and patient management. Each issue adopts a problem-oriented approach, focusing on key questions and clearly outlining what is known while identifying areas for future research. Practical management strategies are described to facilitate application to individual patients. The series targets physicians in practice or training.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信